InvestSMART

Integral Diagnostics Limited (ASX: IDX) - Announcements

Current share price for IDX : $2.220 0.01 (0.45%)+

ASX company news and announcements for Integral Diagnostics Limited (IDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Integral Diagnostics Limited (IDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Integral Diagnostics Limited (IDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Integral Diagnostics Limited (IDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$828 Change of Director's Interest Notice - Toby Hall 4 Dec 2023 10:57AM $1.710 $2.220 risen by 29.82%
$828 Change of Director's Interest Notice - Ingrid Player 4 Dec 2023 10:51AM $1.710 $2.220 risen by 29.82%
$828 Change of Director's Interest Notice - Ian Kadish 1 Dec 2023 9:23AM $1.775 $2.220 risen by 25.07%
$828 Notification regarding unquoted securities - IDX 30 Nov 2023 3:20PM $1.755 $2.220 risen by 26.50%
$828 Final Director's Interest Notice - Helen Kurincic 30 Nov 2023 11:13AM $1.720 $2.220 risen by 29.07%
$828 Results of Annual General Meeting 29 Nov 2023 2:03PM $1.698 $2.220 risen by 30.78%
$828 Becoming a substantial holder 29 Nov 2023 12:10PM $1.675 $2.220 risen by 32.54%
$828 AGM Address and Presentation by Chair and CEO 29 Nov 2023 8:19AM $1.660 $2.220 risen by 33.73%
$828 Ceasing to be a substantial holder 14 Nov 2023 8:13AM $1.805 $2.220 risen by 22.99%
$828 Ceasing to be a substantial holder 13 Nov 2023 4:14PM $1.805 $2.220 risen by 22.99%
$828 Change in substantial holding 10 Nov 2023 2:47PM $1.843 $2.220 risen by 20.49%
$828 FY23 Environment, Social and Governance (ESG) Report 10 Nov 2023 12:58PM $1.830 $2.220 risen by 21.31%
$828 Change in substantial holding - IDX 8 Nov 2023 11:31AM $1.915 $2.220 risen by 15.93%
$828 Trading Update 3 Nov 2023 8:25AM $2.650 $2.220 fallen by 16.23%
$828 4DX: 4DMedical enters contract with Integral Diagnostics 30 Oct 2023 9:05AM $2.650 $2.220 fallen by 16.23%
$828 Notice of Annual General Meeting/Proxy Form 27 Oct 2023 8:55AM $2.560 $2.220 fallen by 13.28%
$828 Release From Escrow 10 Oct 2023 9:31AM $2.790 $2.220 fallen by 20.43%
$828 Application for quotation of securities - IDX 4 Oct 2023 2:16PM $2.780 $2.220 fallen by 20.14%
$828 Initial Director's Interest Notice - Toby Hall 28 Sep 2023 10:33AM $2.850 $2.220 fallen by 22.11%
$828 Retirement of Chair and Appointment of Chair Elect 28 Sep 2023 8:17AM $2.850 $2.220 fallen by 22.11%
$828 Change in substantial holding 25 Sep 2023 4:27PM $2.860 $2.220 fallen by 22.38%
$828 Update - Dividend/Distribution - IDX 25 Sep 2023 2:44PM $2.860 $2.220 fallen by 22.38%
$828 Change of Director's Interest Notice - Ian Kadish 25 Sep 2023 9:34AM $2.900 $2.220 fallen by 23.45%
$828 Notification regarding unquoted securities - IDX 20 Sep 2023 11:31AM $2.860 $2.220 fallen by 22.38%
$828 Change of 2023 Annual general Meeting Date 14 Sep 2023 9:39AM $2.960 $2.220 fallen by 25%

226 - 250 of 784 results

Page 10 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.